Rory S. Miller
Rory Miller, a Partner in Glaser Weil’s Litigation Department, handles a wide variety of business, antitrust and intellectual property disputes from pre-litigation through trial and appeal in courts across the country. Mr. Miller has represented clients of all sizes from individuals to Fortune 100 companies, and has experience with the legal needs of a wide range of industries, including private equity, biotechnology, finance and insurance, entertainment, fashion and manufacturing.
Mr. Miller’s efforts on behalf of the Firm’s clients have led to a number of recognitions and awards, including being named to Benchmark Litigation's 2017 "Under 40 Hot List" and the 2017 Southern California Super Lawyers, Rising Stars list.
Prior to joining the Firm, Mr. Miller practiced law with Quinn Emanuel Urquhart & Sullivan LLP following a clerkship with the late Hon. H. Emory Widener, Jr. of the United States Court of Appeals for the Fourth Circuit.
In law school, Mr. Miller was an executive editor of the UCLA Law Review, as well as a board member and award-winning competitor in UCLA’s Moot Court competition.
Represented William H. Gross in litigation against his former company PIMCO. Obtained a substantial confidential settlement.
Lead counsel for an insurance broker accused of malpractice in the placement of substantial insurance policies. Successfully defeated summary judgment and excluded all evidence of plaintiff’s damages from trial, resulting in settlement for substantially less than the cost of defense.
Lead counsel in several matters involving international contracts and trade with foreign state-owned enterprises addressing questions of sovereign immunity and the act of state doctrine.
Represented biotechnology company accused of infringing patents governing genetic testing for a hereditary disorder. Obtained summary judgment invalidating the patents that was affirmed by the Federal Circuit.
Represented a Fortune 500 company in a $12 billion antitrust action. Member of trial team that secured a defense jury verdict.
Represented a major insurer in connection with claims arising from reinsurance obligations and the 2008 market crash. Secured dismissal of the complaint.
Represented purchaser of a privately held corporation in litigation against the seller for fraudulent misrepresentations during due diligence.
Represented a major private equity firm in litigation arising from its distressed company investment portfolio.
Represented minority shareholder of fashion joint venture in connection with intellectual property and corporate control disputes.
Represented biotechnology company and university in litigation over patents for automated DNA sequencing machines.